Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
345 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (3)

Medical Condition

  • Show all (309)
  • Addiction (2)
  • Autoimmune Disorders (1)
  • (-) Blood Disorders (1)
    • Amyloidosis (1)
  • Cancer (41)
  • COVID-19 (Coronavirus) (1)
  • Developmental Disorders (2)
  • Ear, Nose and Throat (3)
  • Endocrine & Metabolic Disease (1)
  • Eye (1)
  • Healthy Volunteers (35)
  • Heart Disease (1)
  • Infectious Disease (1)
  • Neurological Disorders (174)
  • Obstetrics & Gynecology (2)
  • Pediatrics (10)
  • Psychiatric Disorders (29)
    • ADD/ADHD (1)
    • (-) Anxiety (2)
    • Bipolar Disorder (5)
    • Borderline Personality Disorder (1)
    • Depression (8)
    • Obsessive Compulsive Disorder (OCD) (5)
    • Schizophrenia (4)
  • Stroke (1)
  • Transplant (2)
  • Vascular Conditions (1)
Displaying 1 - 3 of 3

Brain imaging study of anxiety symptoms in adolescents

Condition: Psychiatric Disorders / Anxiety
Investigator: Jonathan Posner, MD
Status: Closed
The goal of this study is to advance our understanding of how the brain processes emotion in adolescents. Adolescents with and without symptoms of anxiety are invited to participate. This study takes place over two days and includes an evaluation and a brain imaging session. Participants will be…
Read More

Brief Treatment for People With Social Anxiety

Condition: Psychiatric Disorders / Anxiety
Investigator: Franklin Schneier, MD
Status: Closed
We are currently enrolling individuals with social anxiety disorder to participate in this study. The purpose of this study is to assess whether a brief computer-based research treatment helps improve social anxiety symptoms. For eligible participants, this study will involve a brief, novel research treatment for social anxiety, delivered in 8 or 12…
Read More

HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

Condition: Blood Disorders / Amyloidosis
Investigator: Thomas Brannagan, MD
Status: Closed
HELIOS-A is a global Phase 3 randomized, open-label study designed to evaluate the safety and efficacy of ALN-TTRSC02 in adult patients with hATTR amyloidosis experiencing neurologic symptoms brought on by the disease. The study will also evaluate any changes in quality of life experienced by study participants. ALN-TTRSC02 utilizes the mechanism of RNA…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science